Sales disappoint, but tax gain lifts Amgen profit
Tax credits helped biotech giant Amgen report first-quarter earnings that beat Wall Street's expectations, but sales growth disappointed investors.
Drugmakers, Interpol ramp up fight against fakes
More than two dozen of the world's largest pharmaceutical companies have agreed to provide funding and other support to Interpol's battle against ...
FDA halts Amgen study after teen patient death
Federal health regulators have halted Amgen's studies of its drug Sensipar after the death of a 14-year-old patient in a company trial. The Food and ...
Southern diet, fried foods, may raise stroke risk
Deep-fried foods may be causing trouble in the Deep South. People whose diets are heavy on them and sugary drinks like sweet tea and soda were more ...
Amgen 4Q profit drops 16 pct. on higher spending
Drugmaker Amgen Inc. on Wednesday posted a 16 percent drop in fourth-quarter profit, as higher costs for production, marketing, research and other ...
Embattled cancer agency's donor list revealed
Major pharmaceutical firms and individuals linked to companies that have benefited from a $3 billion cancer-fighting Texas agency under criminal ...
Final goodbye: Roll call of some who died in 2012
Neil Armstrong would always be taking that first step onto the moon, and Dick Clark was forever "the world's oldest teenager." Some of the notables ...
Amgen to pay $762M settlement over drug marketing
Amgen Inc. has agreed to pay $762 million to resolve federal litigation accusing the drugmaker of marketing the anemia treatment Aranesp for ...
Amgen buying deCODE Genetics for $415 million
Biotech pioneer Amgen Inc., in a bid for a big edge in using people's genetic information to find better ways to attack diseases, is buying human ...
Email
US
International
India
Россия
Română
Singapore
South Africa
México
Indonesia
Brasileira
